Rapamycin Inhibits the Growth and Metastatic Progression of Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapamycin Inhibits the Growth and Metastatic Progression of Non-Small Cell Lung Cancer

Published:2004-01-01 Issue:1 Volume:10 Page:293-300
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Boffa Daniel J.,Luan Fulung,Thomas Dolca,Yang Hua,Sharma Vijay K.,Lagman Milagros,Suthanthiran Manikkam

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relative carcinogenicity of tacrolimus vs mycophenolate after solid organ transplantation and its implications for liver transplant care;World Journal of Hepatology;2024-04-27

2. Integrated Bulk and Single-cell RNA Sequencing Data Constructs and Validates a Prognostic Model for Non-small Cell Lung Cancer;Journal of Cancer;2024

3. Combination of Everolimus and Bortezomib Inhibits the Growth and Metastasis of Bone and Soft Tissue Sarcomas via JNK/p38/ERK MAPK and AKT Pathways;Cancers;2023-04-26

4. Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus;Molecular Biology Reports;2023-01-25

5. The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles;Translational Oncology;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP